The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
NEJM study shows strong protection across strains
The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
Aims to boost speed & precision in patient care
A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
Subscribe To Our Newsletter & Stay Updated
